Institute of Biomedical Research Corp.
MRES · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $22 | $47 | $14 | $15 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $22 | $47 | $14 | $15 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 106.3% | 20.9% | -41.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 47.4% | 22.1% | 35.8% | 56.5% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -1,569.6% | 1,496.4% | -2,140.5% | -3,054.7% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -753.8% | 1,698.6% | -2,536.7% | -3,417% |
| EPS Diluted | -0 | 0 | -0 | -0 |
| % Growth | -200% | 200% | 50% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |